Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study – The Lancet

The effective control of COVID-19 in Australia appears to have mitigated the initialimpact of COVID-19 on systemic cancer therapy….

Published

4 years ago

August 4, 2021

[1].Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel CoronavirusInfected Pneumonia in Wuhan, China.
JAMA.2020; 323: 1061-1069

[2].SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.
JAMA oncology.2020;…

Related Topics:Australia The Lancet

A machine learning approach for predicting risk of schizophrenia using a blood test – Baylor College of Medicine News

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy – News-Medical.Net

Major crash on Gateway Motorway snarls morning commute

Up 34% this year, can Challenger shares keep rising according to Macquarie?

This ASX 200 mining stock is eyeing the lithium throne

Like ‘déjà vu’ all over again?

Noosa Online News